CWCuiping Wang

Cuiping Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Cuiping Wang has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Multi-Omics Analysis Combined with Machine Learning Identified FABP4 in Smooth Muscle Cells as a Pathogenic Factor in Atherosclerosis

    by Yinyu Wang, Tingting Shang, Rui Cai, Cuiping Wang

    Atherosclerosis is the pathological basis of coronary heart disease, stroke, and peripheral arterial disease. Smooth muscle cells (SMCs) play a crucial role in atherosclerotic pathogenesis. However, effective drugs and therapy targeting SMCs for treating atherosclerosis are still lacking. We utilized single-cell RNA sequencing (scRNA-seq) (GSE155512 and GSE159677) and array data (GSE43292 and GSE125771) to identify Scissor+ SMCs (SMCs positively associated with atherosclerosis) and Scissor- SMCs (SMCs negatively associated with atherosclerosis) by using Scissor package. We analyzed their functional changes, cell-cell communication, and differentiation potential. Machine learning techniques were employed to analyze the marker in SMCs of atherosclerosis. qRT-PCR was used to examine the expression of these genes in MOVAS stimulated by ox-LDL. Potential inhibitors of the identified proteins were predicted, and their binding sites were analyzed. We identified 475 Scissor+ SMCs and 1363 Scissor- SMCs. Functional enrichment analysis revealed that Scissor+ SMCs exhibited downregulation of Rho-related pathways, while pro-inflammatory pathways were upregulated. Cell-cell communication analysis indicated tighter interactions between SMCs and endothelial cells. Differential expression analysis identified 20 genes highly expressed in both scRNA-seq and array data. The LASSO regression, random forest, support vector machine and receiver operating characteristic curve suggested a strong correlation between fatty acid-binding protein 4 (FABP4) and atherosclerosis. The qRT-PCR results showed that FABP4 was highly expressed in MOVAS stimulated by ox-LDL. Drug prediction revealed that (S)-RP-6306 acted as an inhibitor, via forming a polar bond with Arg-126. In vitro experiments confirmed that (S)-RP-6306 significantly reduced the expression of FABP4. Scissor+ SMCs differed significantly from Scissor- SMCs in cellular function, cell-cell communication, and differentiation potential. The high expression of FABP4 in this subgroup of SMCs presented a promising therapeutic target for atherosclerosis, with (S)-RP-6306 showing potential as a drug targeting FABP4.


  • Neutrophil extracellular traps: a catalyst for atherosclerosis

    by Yinyu Wang, Cuiping Wang, Jiayan Li

    Neutrophil extracellular traps (NETs) are network-like structures released by activated neutrophils. They consist mainly of double-stranded DNA, histones, and neutrophil granule proteins. Continuous release of NETs in response to external stimuli leads to activation of surrounding platelets and monocytes/macrophages, resulting in damage to endothelial cells (EC) and vascular smooth muscle cells (VSMC). Some clinical trials have demonstrated the association between NETs and the severity and prognosis of atherosclerosis. Furthermore, experimental findings have shed light on the molecular mechanisms by which NETs contribute to atherogenesis. NETs play a significant role in the formation of atherosclerotic plaques. This review focuses on recent advancements in the understanding of the relationship between NETs and atherosclerosis. It explores various aspects, including the formation of NETs in atherosclerosis, clinical trials investigating NET-induced atherosclerosis, the mechanisms by which NETs promote atherogenesis, and the translational implications of NETs. Ultimately, we aim to propose new research directions for the diagnosis and treatment of atherosclerosis.


  • Open Access

    Interactions of ST-elevation myocardial infarction, age, and sex and the risk of major adverse cardiovascular events among Chinese adults: a secondary analysis of a single-centre prospective cohort

    by Cuiping Wang, Lin Zhou, Yi Liang, Peijing Liu, Wei Yuan

    Objectives This study aimed to evaluate the interactions of ST-elevation myocardial infarction (STEMI), ageing and sex with respect to the incidence of major adverse cardiovascular events (MACE) among Chinese adults. Design Secondary analysis of a single-centre prospective cohort. Setting Patients who were admitted to cardiology clinics of the Affiliated Hospital of Jiangsu University due to acute myocardial infarction (MI) from June 2017 to November 2019 were eligible for inclusion in the study. This research only examined in-hospital cases. Participants Patients aged Primary and secondary outcome measures MACE was defined as any occurrence of cardiovascular mortality, MI recurrence, cardiogenic shock or heart failure. The relative excess risk due to interaction (RERI), attributable proportion (AP) and the synergy index were computed to quantify the interactions. Men without STEMI and adults without STEMI aged Results The female participants with STEMI showed a statistically higher risk of MACE compared with the male participants without STEMI (relative risk (RR): 2.713, CI: 1.350 to 5.426, p=0.005). A 3.327 times higher risk of MACE was detected in the older adults with STEMI (aged ≥60 years) compared with the adults without STEMI aged Conclusion In this Chinese population with MI, the risk of MACE was increased by about 2.7 times in women with STEMI compared with men without STEMI. MACE incidence increased by about 3.3 times in older patients with STEMI compared with younger patients without STEMI. STEMI and age, and STEMI and sex, may have a positive additive interaction.


  • Open Access

    Optical Coherence Tomography Evaluating the Culprit Coronary Lesion

    by Jin-Chuan Yan, Cuiping Wang, Yang Zhao, Wei Yuan

    We present a case in which a 64-year-old man was suffering from accelerated angina for 1 week. Conventional coronary angiography and intravascular ultrasound were unable to detect the culprit coronary lesion. However, optical coherence tomography (OCT) obtained superior images to detect a rupture with thin-cap fibroatheroma plaque in the proximal right coronary artery. The symptom of angina disappeared after one coronary stent covering the ruptured plaque. This case indicates that OCT is a new intravascular imaging modality that allows clear visualization of vulnerable plaques.

  • GW25-e4349 Effects of OX40-OX40 ligand interaction on the levels of ROS and Cyclophilin A in C57BL/6J mice' atherogenesis

    by Yan Jinchuan, Ying Li, Zhongqun Wang, Yi Liang, Wei Yuan, Cuiping Wang

    • 1 July 2014
      • Vol. 42  (7) , 566-70

    [CD147 expression level and rs8259 T/A polymorphism of CD147 in patients with acute coronary syndrome].

    by Yu Mao, Jinchuan Yan, Cuiping Wang, Zhongqun Wang, Peijing Liu, Wei Yuan

    To investigate the association between CD147 expression and its untranslated regions 3'UTR rs8259 T/A polymorphism and acute coronary syndrome (ACS). The genotypes of CD147 were detected by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) methods in 182 ACS patients and 328 healthy controls. The plasma level of CD147 was determined by enzyme-linked immunosorbent assay (ELISA). CD147 mRNA and protein expression was detected by real-time fluorescent quantitative PCR (RT-qPCR) and Western blot. The plasma CD147 level obtained from radial artery in ACS patients ((3.63 ± 0.70) pg/L) was significantly higher than in control ((2.45 ± 0.27) pg/L, P < 0.05), and highest in plasma obtained from the coronary artery ((4.28 ± 1.03) pg/L, P < 0.05) in ACS patients. Furthermore, the plasma CD147 level was higher in the ACS patients with rs8259 AA genotype than in the ACS patients with rs8259 TT genotype ((4.08 ± 0.41) pg/L vs. (3.05 ± 0.79) pg/L in radial artery and (5.29 ± 0.62) pg/L vs. (3.13 ± 0.52) pg/L in coronary artery, both P < 0.05). There are an enhanced expression of CD147 mRNA (2.45 times higher than control) and protein (3.66 ± 1.56 vs. 1.81 ± 1.29) in PBMCs from ACS patients than that from controls (both P < 0.05). The PBMCs CD147 mRNA and protein expression level were significantly higher in ACS patients with rs8259 AA genotype (mRNA:2.45 ± 0.35, protein:1.63 ± 0.16) compared to ACS patients with rs8259 TT genotype (mRNA:1.69 ± 0.15, protein: 0.88 ± 0.16, both P < 0.05). Multiple logistic analysis showed that CD147 T allele (AT+TT) was a protective factor to ACS (OR = 0.667, 95% CI 0.507-0.879, P < 0.05). The over-expression of CD147 is involved in the pathogenesis of ACS. The CD147 3'UTR rs8259 T allele may be a protective factor for ACS, its polymorphism can affect the CD147 protein expression in ACS patients.


    • 1 July 2014
      • Vol. 42  (7) , 593-7

    [The impact of cyclophilin A small interfering RNA on the formation of atherosclerotic plaque in apolipoprotein E-deficient mice].

    by Jinchuan Yan, Ying Li, Cuiping Wang, Wei Yuan, Zhongqun Wang

    The aim of this study was to determine whether inhibition of cyclophilin A by lentivirus-mediated RNA interference (RNAi) could inhibit progression of atherosclerotic plaques and increase collagen production. Atherosclerostic plaque model was induced by rapid perivascular carotid silicone collar placement in ApoE(-/-) mice. The recombinant CyPA-RNAi-Lentivirus (CyPA-RNAi-LV) or negative control-green fluorescent protein-Lentivirus (NC-GFP-LV) were constructed and transfected into right carotid plaques, respectively. Using the local injection method, ApoE(-/-) mice carotid artery plaque were intervened 10 min in the silicone collar placement with 10 µl (1.0 × 10⁸ TU/ml) lentivirus vector. The areas and CyPA expression of plaques were analyzed by morphological observation, real-time polymerase chain reaction (RT-PCR) and Western blot respectively. CyPA-RNAi-LV not only prevented plaques progression ((9 085 ± 671) µm² to (18 021 ± 1 901) µm²), but also decreased plaque lipid content ((28.9 ± 6.3)% to (17.8 ± 4.5)%), increased plaque collagen content ((24.2 ± 4.8)% to (35.1 ± 5.2)%) at 6 weeks after lentivirus transfection. The intima/media ratio (0.36 ± 0.11 vs. 0.65 ± 0.12, P < 0.05) and degree of lumen stenosis (intima/lumen ratios, 0.18 ± 0.02 vs. 0.33 ± 0.03, P < 0.05) were also significantly reduced by CyPA-RNAi-LV. Moreover, RT-PCR analysis revealed downregulated expressions of proinflammatory cytokines and matrix metalloproteinases (MMP-9 -17.5%) in the CyPA-RNAi-LV group. Lentivirus-mediated CyPA silencing by siRNA could inhibit plaques progression and reduce local inflammation through the anti-inflammatory effects in this model.

    • 1 December 2013
      • Vol. 41  (12) , 1059-60

    [A case report of two pulmonary vein occlusion after atrial fibrillation catheter ablation].

    by Jin-Chuan Yan, Cui-Ping Wang, Yi Liang, Rong-Zeng Du